The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

DPP1 inhibitor brensocatib has been submitted for approval by the FDA for non-cystic fibrosis bronchiectasis based on the results of the ASPEN trial, which showed that the drug cut the number of ...

The article titled "Effects of the DPP-1 Inhibitor HSK31858 in Adults with Bronchiectasis in China (SAVE-BE): A Phase 2, Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial," focuses on ...

Percent-predicted FEV1 measured before pregnancy did not fall 1 year after in women with highly effective cystic fibrosis ...

【Translation】 According to the CDE website, HSK31858, a Class 1 new drug, was included in the breakthrough therapy designation in 2024 for non-cystic fibrosis bronchiectasis, becoming the ...

Find effective medications for 'Bronchiectasis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...

Considering taking supplements to treat bronchiectasis? Below is a list of common natural remedies used to treat or reduce the symptoms of bronchiectasis. Follow the links to read common uses ...

Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Murray et al, Eur Respir J 2009, DOI: 10.1183/09031936.00163208 Colour of phlegm can predict outcomes for patients with ...

Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis ... along with presence of extensive bronchiectasis consistent with ABPA ...

To participate, please dial one of the following numbers and ask to join the Verona Pharma call: A live webcast will be available on the Events and Presentations link on the Investors page of the ...

cystic fibrosis, asthma, interstitial lung disease, bronchiectasis, benign and malignant neoplasms, and lung transplantation. The Lung Institute has developed a comprehensive program across ...